孕期的艾滋病病毒：识别分娩期及围产期艾滋病病毒暴露情况。
HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures.
作者信息
Moore Dorothy L, Allen Upton D
机构信息
Canadian Paediatric Society, Infectious Diseases and Immunization Committee, Ottawa, Ontario.
出版信息
Paediatr Child Health. 2019 Feb;24(1):42-49. doi: 10.1093/pch/pxy181. Epub 2019 Feb 15.
Abstract
The benefits of human immunodeficiency virus (HIV) testing in pregnancy, when combined with appropriate maternal antiretroviral therapy and intrapartum and postnatal prophylaxis, are well established. The vertical rate of transmission of HIV in North America is now well below 2%. Efforts must continue to ensure that these benefits are sustained. Women who have received little or no prenatal care and those who present for delivery with unknown HIV status need immediate testing. As more infants are exposed to antiretroviral agents, strategies need to be implemented to ensure adequate follow-up of these infants. Issues relating to the identification of HIV-exposed infants are highlighted.
摘要
妊娠期间进行人类免疫缺陷病毒（HIV）检测，若结合适当的孕产妇抗逆转录病毒治疗以及分娩期和产后预防措施，其益处已得到充分证实。目前，北美地区HIV的垂直传播率远低于2%。必须继续努力以确保维持这些益处。几乎未接受或未接受产前护理的妇女以及分娩时HIV感染状况不明的妇女需要立即进行检测。随着越来越多的婴儿接触抗逆转录病毒药物，需要实施相应策略以确保对这些婴儿进行充分的随访。文中突出了与识别HIV暴露婴儿相关的问题。
相似文献
1
HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures.
Paediatr Child Health. 2019 Feb;24(1):42-49. doi: 10.1093/pch/pxy181. Epub 2019 Feb 15.
2
Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Pediatrics. 2003 May;111(5 Pt 2):1186-91.
3
Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):313-322. doi: 10.1097/QAI.0000000000002350.
4
Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013.
JAMA Pediatr. 2017 May 1;171(5):435-442. doi: 10.1001/jamapediatrics.2016.5053.
5
Prevention of perinatal transmission of human immunodeficiency virus.
Infect Dis Clin North Am. 2014 Dec;28(4):529-47. doi: 10.1016/j.idc.2014.08.002. Epub 2014 Nov 20.
6
HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
Pediatrics. 2008 Nov;122(5):1127-34. doi: 10.1542/peds.2008-2175.
7
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
JAMA. 2002 Jul 10;288(2):189-98. doi: 10.1001/jama.288.2.189.
8
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.
9
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
N Engl J Med. 2004 Jul 15;351(3):229-40. doi: 10.1056/NEJMoa041305. Epub 2004 Jul 9.
10
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
引用本文的文献
1
Factors associated with knowledge on HIV, TB and malaria among pregnant women and their perception of access to RDTs for HIV, TB and malaria in Savannakhet Province, Lao PDR.
BMC Pregnancy Childbirth. 2025 Apr 12;25(1):438. doi: 10.1186/s12884-025-07543-x.
2
Gender Equity and Vertically Transmitted Infections: A Country-Level Analysis Across 153 Countries.
Health Equity. 2021 Jan 25;5(1):23-29. doi: 10.1089/heq.2020.0097. eCollection 2021.
3
Social Determinants of Breastfeeding Preferences among Black Mothers Living with HIV in Two North American Cities.
Int J Environ Res Public Health. 2020 Sep 21;17(18):6893. doi: 10.3390/ijerph17186893.
本文引用的文献
1
Guidelines for the care of pregnant women living with HIV and interventions to reduce perinatal transmission: executive summary.
J Obstet Gynaecol Can. 2014 Aug;36(8):721-734. doi: 10.1016/S1701-2163(15)30515-6.
2
Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.
Clin Infect Dis. 2014 Nov 1;59(9):1332-45. doi: 10.1093/cid/ciu586. Epub 2014 Jul 22.
3
Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
BMC Infect Dis. 2014 May 5;14:236. doi: 10.1186/1471-2334-14-236.
4
Prevention of vertical HIV transmission and management of the HIV-exposed infant in Canada in 2014.
Can J Infect Dis Med Microbiol. 2014 Mar;25(2):75-7. doi: 10.1155/2014/526019.
5
In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.
AIDS. 2014 Jun 19;28(10):1421-30. doi: 10.1097/QAD.0000000000000292.
6
Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants.
PLoS Med. 2014 Apr 29;11(4):e1001636. doi: 10.1371/journal.pmed.1001636. eCollection 2014 Apr.
7
Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis.
PLoS Med. 2014 Feb 25;11(2):e1001608. doi: 10.1371/journal.pmed.1001608. eCollection 2014 Feb.
8
Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.
Pediatr Infect Dis J. 2014 Jul;33(7):734-40. doi: 10.1097/INF.0000000000000224.
9
Association of recent HIV infection and in-utero HIV-1 transmission.
AIDS. 2011 Jul 17;25(11):1357-64. doi: 10.1097/QAD.0b013e3283489d45.
10
Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study.
BMJ. 2010 Dec 22;341:c6580. doi: 10.1136/bmj.c6580.
Zotero 插件